10 
the United States (whether or not federally funded) and would include at 
least the following regulatory requirements: 
(1) Review of such research by an institutional biohazards committee 
before it is undertaken. 
(2) Compliance with physical and biological containment standards 
and prohibitions in the NIH Guidelines. 
(3) Registration of such research with a national registry at the 
time this research is undertaken (subject to appropriate 
safeguards to protect proprietary interests) . 
(4) Enforcement of the above requirements through monitoring, 
inspection, and sanctions. 
It was the conclusion of the Subcommittee that present law could 
permit imposition of some of the above requirements on much laboratory 
research involving recombinant DNA techniques, but that no single legal 
authority or combination of authorities currently existed that would 
clearly reach all research and other uses of recombinant DNA techniques 
and meet all stated requirements. Although there is existing authority 
that might be interpreted broadly to cover most of the research at issue, 
it was generally agreed that regulatory actions taken on the basis of any 
such interpretation would probably be subject to legal challenge. The 
Subcommittee, in reaching this conclusion, reviewed the following laws 
that were deemed to warrant detailed consideration: 
[ 851 ] 
